Use of the word “cured” for cancer patients—implications for patients and physicians: The Siracusa charter

Current Oncology

Volumn 22, Issue 1, 2015, Pages e38-e40

  Tralongo, Paolo ^a   Dal Maso, L ^b   Surbone, A ^c   Santoro, A ^d   Tirelli, U ^p   Sacchini, V ^r   Pinto, C ^e   Crispino, S ^f   Ferrau F ^g   Mandoliti, G ^h   Tonini, G ⁱ   Russo, A ^j   Santini, D ⁱ   Madeddu, A ⁿ   Panebianco, V ^g   Pergolizzi, S ^k   Respini, D ^o   Rolfo, C ^l   Bongiovanni, M ^q   De Lorenzo, F ⁿ   Spatola, C ⁿ   Di Raimondo, F ^m   Terenziani, M ^s   Peeters, M ^l   Castoro, C ⁿ   more..

^a Umberto I Hospital   (Italy)

^b Epidemiology and Biostatistics Unit   (Italy)

^c NEW YORK UNIVERSITY   (United States)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY HOSPITAL OF PARMA   (Italy)

^f Oncology Department   (Italy)

^g San Vincenzo Hospital   (Italy)

^h Radiotherapy Oncology Unit   (Italy)

ⁱ UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^j UNIVERSITY OF PALERMO   (Italy)

^k UNIVERSITY OF MESSINA   (Italy)

^l ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^m Public Hospital Ferrarotto   (Italy)

ⁿ Mareluce Onlus ^*  (Italy)

^o Mareluce Onlus   (Italy)

^p Cro ircss   (Italy)

^q Angolo Onlus   (Italy)

^r MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^s NATIONAL CANCER INSTITUTE   (Italy)

more..

Author keywords

Cure; Implications; Long term survival

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CANCER SURVIVOR; CANCER THERAPY; GENERAL PRACTITIONER; HUMAN; INTERPERSONAL COMMUNICATION; ITALY; LONG TERM SURVIVAL; MEDICAL LITERATURE; ONCOLOGIST; PHYSICIAN; SOLID TUMOR;

EID: 84922874858     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.22.2287     Document Type: Article

References (17)

1. De Angelis R, Sant M, Coleman MP, et al. on behalf of the eurocare-5 Working Group. Cancer survival in Europe 1999–2007 by country and age: results of eurocare-5—a population-based study. Lancet Oncol 2014;15:23–34.
2. Tralongo P, Annunziata MA, Santoro A, Tirelli U, Surbone A. Beyond semantics: the need to better categorize patients with cancer. J Clin Oncol 2013;31:2637–8.
3. Surbone A, Annunziata MA, Santoro A, Tirelli U, Tralongo P. Cancer patients and survivors: changing words or changing culture? Ann Oncol 2013;24:2468–71.
4. Baade PD, Youlden DR, Chambers SK. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust 2011;194:73–7. [Erratum in: Med J Aust 2011;194:376]
5. Ellison LF, Bryant H, Lockwood G, Shack L. Conditional survival analyses across cancer sites. Health Rep 2011; 22: 21–5.
6. Janssen–Heijnen ML, Gondos A, Bray F, et al. Clinical relevance of conditional survival of cancer patients in Europe: age-specifc analyses of 13 cancers. J Clin Oncol 2010;28:2520–8.
7. Småstuen M, Aagnes B, Johannesen TB, Møller B, Bray F. Long-term cancer survival: patterns and trends in Norway 1965–2007. Oslo, Norway: Cancer Registry of Norway; 2008. [Available online at: http://www.kreftregisteret.no/Global/Publikasjoner%20og%20rapporter/CIN2007_del2.pdf; cited December 3, 2014]
8. Andrae B, Andersson TM, Lambert PC, et al. Screening and cervical cancer cure: population based cohort study. BMJ 2012;344:e900.
9. Janssen–Heijnen ML, van Steenbergen LN, Voogd AC, et al. Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands. Ann Oncol 2014;25:64–8.
10. Francisci S, Capocaccia R, Grande E, et al. on behalf of the eurocare Working Group. The cure of cancer: a European perspective. Eur J Cancer 2009;45:1067–79.
11. Woods LM, Rachet B, Lambert PC, Coleman MP. “Cure” from breast cancer among two populations of women followed for 23 years after diagnosis. Ann Oncol 2009;20:1331–6.
12. airtum Working Group. Italian cancer figures, report 2011. Survival of cancer patients in Italy. Epidemiol Prev 2011;35(suppl 3):1–200. [Original report downloadable from: http://www.registri-tumori.it/cms/Rapp2011Indice; cited November 24, 2014]
13. Hay ID. Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract 2007;13:521–33.
14. Carver BS, Motzer RJ, Kondagunta GV, Sogani PG, Sheinfeld J. Late relapse of testicular germ cell tumors. Urol Oncol 2005;23:441–5.
15. Ehrlich Y, Rosenbaum E, Baniel J. Late relapse of testis cancer. Curr Urol Rep 2013;14:518–24.
16. Daugaard G, Gundgaard MG, Mortensen MS, et al. Surveillance for stage i nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. J Clin Oncol 2014;32:3817–23.
17. Dal Maso L, Guzzinati S, Buzzoni C, et al. on behalf of the airtum Working Group. Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818,902 Italian patients and 26 cancer types. Ann Oncol 2014;25:2251–60.